Recall: D-0900-2023

Class II - Potentially Harmful

Class IIClassification
2023-02-09Initiated
TerminatedStatus
L. Perrigo CompanyFirm

Product

Allergy, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a) 30-count cartons (NDC 72288-847-39), and b)150-count cartons (NDC 72288-847-47 and 72288-847-37), Distributed By: Amazon.com Services LLC., 410 Terry Avenue N., Seattle, WA 98109.

Reason

Failed Impurities/Degradation Specifications

Distribution

Nationwide within the USA

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.